Stryker Corporation
SYK
Clasificación en acciones
#190
Stryker Corporation functions as a prominent medical technology enterprise,... Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replacement procedures (including hips and knees), as well as solutions for trauma and extremities surgeries. This division also furnishes a comprehensive suite of spinal implant products, such as cervical, thoracolumbar, and interbody systems, utilized in addressing spinal injuries, deformities, and degenerative conditions. The MedSurg and Neurotechnology division offers an extensive array of products, encompassing advanced surgical equipment, surgical navigation systems, endoscopic and communication tools, patient handling devices, emergency medical apparatus, and critical care disposable items. This segment also deals in reprocessed and remanufactured medical devices, catering to various medical specialties. Furthermore, its neurotechnology offerings include devices for minimally invasive endovascular techniques, instruments for brain and open skull-based surgical interventions, and orthobiologic and biosurgery products like synthetic bone grafts and vertebral augmentation solutions. It also provides specialized minimally invasive products for treating acute ischemic and hemorrhagic strokes, alongside craniomaxillofacial implants, which include cranial, maxillofacial, and chest wall devices, in addition to dural substitutes and sealants. Stryker distributes its diverse portfolio to medical professionals, hospitals, and other healthcare institutions in approximately 75 countries, leveraging its network of company-owned subsidiaries, regional branches, and independent dealers and distributors. Established in 1941, Stryker Corporation is headquartered in Kalamazoo, Michigan.
Precio por acción
$304.72
Última sincronización: 2026-10-20
Capitalización bursátil
$116.88B
Cambio (1 día)
1.96%
Cambio (1 año)
-19.76%
País
US
Comercio Stryker Corporation (SYK)
Categoría
Healthcare
Ratio P/E de Stryker Corporation (SYK)
Ratio P/E al October 2026 TTM: 28.94
Según los últimos informes financieros y el precio de las acciones de Stryker Corporation, el P/E actual (TTM) de la empresa es 28.94. Al final de 2024, la empresa tenía un P/E de 45.83.
Historial del ratio P/E de Stryker Corporation desde 2000 hasta 2026
Relación P/E al final de cada año
| Año | Ratio P/E | Cambiar |
|---|---|---|
| 2026 (TTM) | 28.94 | -30.05% |
| 2025 | 41.38 | -9.71% |
| 2024 | 45.83 | 27.61% |
| 2023 | 35.92 | -8.41% |
| 2022 | 39.21 | -22.44% |
| 2021 | 50.56 | -12.14% |
| 2020 | 57.54 | 52.66% |
| 2019 | 37.69 | 128.39% |
| 2018 | 16.50 | -70.93% |
| 2017 | 56.77 | 108.63% |
| 2016 | 27.21 | 11.88% |
| 2015 | 24.32 | -64.92% |
| 2014 | 69.33 | 145.16% |
| 2013 | 28.28 | 75.92% |
| 2012 | 16.07 | 12.53% |
| 2011 | 14.28 | -14.55% |
| 2010 | 16.72 | -7.52% |
| 2009 | 18.08 | 27.26% |
| 2008 | 14.20 | -52.79% |
| 2007 | 30.09 | 4.28% |
| 2006 | 28.85 | 8.62% |
| 2005 | 26.56 | -36.09% |
| 2004 | 41.57 | 6.61% |
| 2003 | 38.99 | -3.57% |
| 2002 | 40.43 | -4.42% |
| 2001 | 42.30 | -5.53% |
| 2000 | 44.78 | 0.00% |
Relación P/E para empresas similares o competidores
| Empresa | P/E Ratio | Diferencia del P/E Ratio | País |
|---|---|---|---|
| 33.11 | 14.39% |
US
|
|
| 21.39 | -26.11% |
IE
|
|
| 17.34 | -40.10% |
US
|
|
| - | - |
DE
|
|
| 49.68 | 71.65% |
US
|
¿Cómo leer un P/E ratio?
El ratio Precio/Beneficio (P/E Ratio) mide la relación entre el precio de las acciones de una empresa y sus beneficios por acción.
Un P/E bajo pero positivo indica una empresa con altos beneficios en relación a su valoración actual y que podría estar infravalorada. Una empresa con un P/E negativo alto (cerca de 0) indica fuertes pérdidas en comparación con su valoración.
Las empresas con un P/E superior a 30 o negativo suelen considerarse "acciones de crecimiento", lo que significa que los inversores esperan que crezca o se vuelva rentable en el futuro.
Las empresas con un P/E positivo inferior a 10 suelen considerarse "acciones de valor", lo que significa que ya son muy rentables y no se espera un fuerte crecimiento.